Clinical & Provider Software
Applied AI
Collate builds AI software that drafts the regulatory, clinical, and quality documents life sciences companies produce to develop and sell drugs, diagnostics, and medical devices. Teams load source documents and reference material into its platform, which drafts protocols, reports, standard operating procedures, and regulatory filings, and a person reviews each document before it is exported. The company addresses the paperwork that slows each stage of a product's path from research to market approval, work that companies otherwise write by hand or send to outside firms.
Surbhi Sarna, Collate CEO: A Fortt Knox Conversation
AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork
Collate Acquires MantleBio
With gen AI, Merck and McKinsey transform clinical authoring
This YC Partner Just Raised $30 Million For An AI Startup Automating Paperwork For Biotech
Introducing Collate
Generative AI in the pharmaceutical industry: Moving from hype to reality